Federal Select Agent Program Clarifies Requirements for Botulinum Neurotoxin Gene Constructs Health Security May 4, 2022 …
New Research on Building Blocks of Poxviruses Could Lead to Antiviral Drugs Medical Countermeasures April 10, 2022 …
Ebola Virus Can ‘Hide Out’ in the Brain After Treatment and Cause Recurrent Infections Pathogens March 15, 2022 …
Appili Awarded $10M in New Biodefense Funding for Tularemia Vaccine Candidate Industry News March 3, 2022 …
U.S. Government to Conduct Sweeping Review of Biosecurity Policy Frameworks Biosecurity February 28, 2022 …
Novel Antibiotic Shows Success in Treatment of Plague and Melioidosis Antimicrobial Resistance February 17, 2022 …
Submit Comments on Draft Policy Statement for BSL-4 Laboratory Verification Biosecurity February 6, 2022 …
Bucknell Researchers Head to Uganda to Study African Bats’ Immune Response to Ebola Virus Biosecurity February 6, 2022 …
NIAID Pandemic Preparedness Plan Aims to Bolster Studies for ‘Prototype’ Pathogens Policy + Initiatives February 6, 2022 …
Complete Protection Against Yersinia pestis by Immunization with Inhalable rF1-V10 Fusion Protein Medical Countermeasures February 2, 2022 …
Elusys Therapeutics Finalizes HHS Contract to Deliver Inhalation Anthrax Treatment Medical Countermeasures January 31, 2022 …
The U.S. Government Responds to False Allegations Targeted at the DoD Cooperative Threat Reduction Program Biosecurity January 11, 2022 …
DHS Opens Small Business Solicitation for Biological, Chemical Threat Detection CBRNE December 21, 2021 …
